Yohei Ando
Kyushu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yohei Ando.
Pancreatology | 2017
Sho Endo; Kohei Nakata; Akiko Sagara; Kazuhiro Koikawa; Yohei Ando; Shin Kibe; Shin Takesue; Hiromichi Nakayama; Toshiya Abe; Takashi Okumura; Taiki Moriyama; Yoshihiro Miyasaka; Kenoki Ohuchida; Takao Ohtsuka; Kazuhiro Mizumoto; Masafumi Nakamura
BACKGROUND Salinomycin has cytotoxic effects on various types of malignancy and induces autophagy. However, it has not been clarified whether autophagy induced by salinomycin treatment has a protective or cytotoxic role. We investigated whether salinomycin affects autophagy in pancreatic cancer cells and whether autophagy induced by salinomycin treatment has a protective or cytotoxic role in these cells. METHODS We investigated the effect of salinomycin using three pancreatic cancer cell lines. We investigated effect on proliferation and the CD133 positive fraction using flow cytometry. In addition, we monitored the change in autophagic activity after salinomycin treatment using fluorescent immunostaining, western blotting, and flow cytometry. Finally, knockdown of ATG5 or ATG7 by siRNA was used to investigate the impact of autophagy inhibition on sensitivity to salinomycin. RESULTS Salinomycin suppressed the proliferation of pancreatic cancer cells in a concentration dependent manner, and reduced the CD133 positive fraction. Salinomycin enhanced autophagy activity in these cells in a concentration dependent manner. Autophagy inhibition made pancreatic cancer cells more sensitive to salinomycin. CONCLUSIONS Our data provide the first evidence indicating that autophagy induced by salinomycin have a protective role in pancreatic cancer cells. A new therapeutic strategy of combining salinomycin, autophagy inhibitors, and anticancer drugs could hold promise for pancreatic cancer treatment.
Pancreas | 2016
Masafumi Nakamura; Hideo Matsumoto; Hiroshi Nakashima; Yohei Ando; Toshihiro Hirai; Koji Yoshida; Keisuke Hino
magnifications (A, bar = 200 μm; B, bar = 100 μm; C, bar = 50 μm). Some areas were presented in a highmagnification (D–F, bar = 10 μm). D, The arrow indicates a nucleus of a high endothelial cell, and the arrowhead indicates a transmigrating lymphocyte. E, The arrow indicates an erythrocyte, and the arrowhead indicates a transmigration lymphocyte. F, The arrow indicates a nucleus of a high endothelial cell, and the arrowhead indicates an erythrocyte. Pancreas • Volume 45, Number 3, March 2016 Letters to the Editor
International Journal of Cancer | 2018
Takashi Okumura; Kenoki Ohuchida; Shin Kibe; Chika Iwamoto; Yohei Ando; Shin Takesue; Hiromichi Nakayama; Toshiya Abe; Sho Endo; Kazuhiro Koikawa; Masafumi Sada; Kohei Horioka; Naoki Mochidome; Makoto Arita; Taiki Moriyama; Kohei Nakata; Yoshihiro Miyasaka; Takao Ohtsuka; Kazuhiro Mizumoto; Yoshinao Oda; Makoto Hashizume; Masafumi Nakamura
Although recent studies revealed that adipose tissue accelerates pancreatic tumor progression with excessive extracellular matrix, key players for desmoplasia in the adipose microenvironment remains unknown. Here, we investigated the roles of adipose tissue‐derived stromal cells (ASCs) in desmoplastic lesions and tumor progression by in vitro and in vivo experiments. In a three‐dimensional (3‐D) organotypic fat invasion model using visceral fat from CAG‐EGFP mice, GFP‐positive fibroblastic cells infiltrated toward cancer cells. When tumor cells were inoculated into transplanted visceral fat pads in vivo, tumor weights and stromal components were enhanced compared to subcutaneous and orthotopic tumor cells inoculated without fat pads. Expression of αSMA in established human ASCs was lower compared to cancer associated fibroblasts, and the 3‐D collagen matrices produced by ASCs cultured in cancer cell‐conditioned medium changed from loose to dense structures that affected the motility of cancer cells. Microarray analyses revealed upregulation of S100A4 in ASCs, while S100A4‐positive stromal cells were observed at extrapancreatic invasion sites of human pancreatic cancer. The present findings indicate that ASCs are recruited to extrapancreatic invasion sites and produce dense collagen matrices that lead to enhanced tumor progression. Both inhibition of ASCs recruitment and activation could lead to a novel antistromal therapy.
Cancer Letters | 2018
Kazuhiro Koikawa; Kenoki Ohuchida; Yohei Ando; Shin Kibe; Hiromichi Nakayama; Shin Takesue; Sho Endo; Toshiya Abe; Takashi Okumura; Chika Iwamoto; Taiki Moriyama; Kohei Nakata; Yoshihiro Miyasaka; Takao Ohtsuka; Eishi Nagai; Kazuhiro Mizumoto; Makoto Hashizume; Masafumi Nakamura
Stroma invasion is an important step in pancreatic cancer progression. However, how pancreatic ductal adenocarcinoma (PDAC) with ductal structure invades the surrounding stroma has not been clear. Here, we elucidated the mechanism of stromal invasion of PDAC, using organoids. From resected PDAC specimens, we established human PDAC organoids, which developed ductal and basement membrane (BM) structures. When the organoids were co-cultured with pancreatic stellate cells (PSCs) in a collagen matrix, organoids lost their BM and ductal structures, and invaded collagen matrix more frequently than did mono-cultured organoids. Interestingly, direct contact by PSCs to PDAC organoids was observed before BM destruction. Matrix metalloproteinase (MMP) 2 or membrane type-1 MMP (MT1MMP) knockdown in PSCs significantly attenuated BM destruction by PSCs, and retained the ductal structures in organoids. Our results imply that direct contact by PSCs induces BM destruction and stromal invasion of PDAC via MMP2 which binds to MT1MMP on PSCs.
Cancer Letters | 2018
Kazuhiro Koikawa; Kenoki Ohuchida; Shin Takesue; Yohei Ando; Shin Kibe; Hiromichi Nakayama; Sho Endo; Toshiya Abe; Takashi Okumura; Kohei Horioka; Masafumi Sada; Chika Iwamoto; Taiki Moriyama; Kohei Nakata; Yoshihiro Miyasaka; Riichi Ohuchida; Tatsuya Manabe; Takao Ohtsuka; Eishi Nagai; Kazuhiro Mizumoto; Makoto Hashizume; Masafumi Nakamura
Gastroenterology | 2018
Shin Kibe; Kenoki Ohuchida; Yohei Ando; Shin Takesue; Hiromichi Nakayama; Toshiya Abe; Sho Endo; Kazuhiro Koikawa; Takashi Okumura; Koji Shindo; Taiki Moriyama; Kohei Nakata; Shuntaro Nagai; Yoshihiro Miyasaka; Takao Ohtsuka; Kazuhiro Mizumoto; Masafumi Nakamura
Gastroenterology | 2018
Yohei Ando; Kenoki Ohuchida; Shin Kibe; Shin Takesue; Hiromichi Nakayama; Kazuhiro Koikawa; Koji Shindo; Taiki Moriyama; Kohei Nakata; Yoshihiro Miyasaka; Takao Ohtsuka; Kazuhiro Mizumoto; Masafumi Nakamura
Gastroenterology | 2018
Chika Iwamoto; Kenoki Ohuchida; Takashi Okumura; Kazuhiro Koikawa; Shin Takesue; Hiromichi Nakayama; Sho Endo; Shin Kibe; Yohei Ando; Kohta Miyawaki; Masaharu Murata; Koichi Akashi; Masafumi Nakamura; Makoto Hashizume
Gastroenterology | 2018
Kazuhiro Koikawa; Kenoki Ohuchida; Yohei Ando; Shin Kibe; Hiromichi Nakayama; Shin Takesue; Sho Endo; Toshiya Abe; Takashi Okumura; Chika Iwamoto; Koji Shindo; Taiki Moriyama; Kohei Nakata; Yoshihiro Miyasaka; Takao Ohtsuka; Kazuhiro Mizumoto; Masafumi Nakamura
Annals of Pancreatic Cancer | 2018
Kazuhiro Koikawa; Kenoki Ohuchida; Yohei Ando; Shin Kibe; Hiromichi Nakayama; Shin Takesue; Sho Endo; Toshiya Abe; Takashi Okumura; Chika Iwamoto; Koji Shindo; Taiki Moriyama; Kohei Nakata; Yoshihiro Miyasaka; Takao Ohtsuka; Eishi Nagai; Kazuhiro Mizumoto; Makoto Hashizume; Masafumi Nakamura